They are not an independent accreditation of Zevay, its affiliated medical group, or its pharmacy partners by this article - this article did not audit Zevay's licensing, verify provider credentials, or inspect its pharmacy partners' facilities
The unregulated use of BPC-157 poses a serious risk, as its safety profile in humans remains unknown due to a lack of comprehensive clinical studies
This creates confusion when different people think they are talking about the same thing but have different understandings
*Correspondence: Luhua Lai, [email protected] This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
However, if you provide us with recent lab results, we can use those for monitoring purposes instead